Study at a glance
What was studied?
This review compares ten studies of defence in the gut and airway linings. Researchers studied human cells and tissue, mice and people in trials. They measured local vitamin D activation, defence substances, microbial control and clinical infections.
What was found?
Airway cells could convert a vitamin D precursor into active hormone. Precursor means a form that requires activation. Human colon tissue, from part of the large intestine, responded to precursor, but its hormone-production rate was not directly measured. Mouse gut infection studies gave conflicting results. A small airway-liquid trial did not establish a clear difference between treatments. CORONAVIT did not clearly reduce respiratory infections with its six-month testing-and-supplement offer.
What does it mean?
A stronger gene response, altered inflammation, bacterial growth in a tissue and infection in a person are different outcomes. Local responses do not by themselves establish clinical protection.
What are the limits?
Genetically removing the receptor, the protein enabling cells to respond to hormone, is different from lowering vitamin D supply or adding active hormone directly. Related studies shared investigators or a parent trial. Some human comparisons were small. In CORONAVIT, many comparison participants also used supplements. These findings do not establish one universal improvement in defence or a personal supplement dose.
Read the full article below ↓Cells responding to active vitamin D can change aspects of gut and airway defence. The studies measured different things: local hormone activation, cell signals, antimicrobial activity, bacteria establishing themselves in a tissue and human infections. These results cannot be treated as one universal increase in protection. Antimicrobial activity means activity against microbes. The detailed counterpart is Vitamin D, Mucosal Surveillance and Local Gut and Airway Defence: Full Evidence Review.
What was studied?
Mucosal surfaces are the linings of places such as the gut and respiratory tract. They must respond to microbes while maintaining tissue function. The review compared ten underlying studies involving human cells, human tissue, mouse models and clinical trials. Some programmes shared investigators; different publications from CORONAVIT were one parent trial.
Calcitriol is the active vitamin D hormone. The circulating precursor 25-hydroxyvitamin D3 is a form that cells can convert to active hormone. Adding active hormone directly to cells is different from taking vitamin D3 by mouth.
What did the airway studies show?
Primary human airway cells could convert precursor into active hormone and change selected defence-related responses. This was direct evidence of local activation under the tested conditions. It did not show fewer infections. A measurement of cathelicidin-related protein did not fully establish how much of it was processed into the form with antimicrobial activity. [1]
In another airway-cell experiment, calcitriol reduced some inflammatory signals after respiratory syncytial virus exposure without a detected increase in measured virus multiplication. This does not prove every antiviral function was identical or establish treatment benefit in patients. [2]
A small randomized trial tested bacterial killing by airway liquid taken from participants. Forty people supplied analysable samples. Participants were assigned by chance to vitamin D or placebo, a comparison without vitamin D. One group’s change met the paper’s statistical threshold and the other did not. This did not establish that the treatment effects differed between groups. The assay measured activity outside the body, not fewer clinical infections. [3]
These findings concern mechanisms relevant to Vitamin D and Lung Function. They do not demonstrate improved lung function or a treatment for respiratory infection.
Was local gut metabolism established in the same way?
Human colon tissue, from part of the large intestine, responded to precursor and active hormone with changes in gene activity. That showed responsiveness, but did not directly measure the rate of active-hormone production or microbial killing. It should not be described as the same conversion measurement used in the airway study. [4]
In mice, removing the receptor from gut lining cells changed stored material and measured proteins in Paneth cells, which contribute substances involved in gut defence. It also changed the microbes present. The receptor is a protein that allows cells to respond to active vitamin D. The experiment did not measure the full speed of breakdown and reuse of cell material, protection in people or benefit from supplements. [5]
Why do the mouse infection findings need qualification?
One study of mice lacking the receptor found that bacteria were initially less able to establish themselves in the gut. This depended on the microbes already present. Antibiotic alteration reversed that apparent protection. A different dietary and metabolic study found impaired defence with deficiency. Another programme found worse infection with receptor loss. [6] [7] [8]
These conflicting results cannot be settled by counting papers. Removing the receptor, lowering vitamin D supply, changing when mice were exposed during development and altering existing microbes are different experiments. The experiments do not establish one direction for every human mucosal immune response. Their relationship to Vitamin D and Innate Immunity is specific, rather than a general claim of stronger or weaker immunity.
What did human trials add?
The small trial in Crohn’s disease, a condition causing gut inflammation, studied people whose disease was relatively quiet. It did not establish between-group benefits for passage through the gut lining, blood LL-37 or disease markers. LL-37 is a substance with antimicrobial activity. A blood measurement did not directly measure release of that substance at the gut surface. The physical barrier and its immune defences are related, but remain different questions, as explained through Vitamin D and Barrier Immunity. [9]
CORONAVIT offered a blood test and supplements if vitamin D was below the study’s threshold. This policy did not clearly reduce respiratory infections over six months. Many people assigned to the comparison group also used supplements. Infections were uncommon, and information on particular groups was limited. The result does not prove that local responses are absent, but those responses cannot be presented as proven protection in people. [10]
Vitamin D responses differed between tissues, and benefit in people remains uncertain. Stronger gene activity, less inflammation, less establishment of bacteria in the gut and fewer infections remain separate outcomes.
Primary sources
[1] Hansdottir S et al. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. Journal of immunology (Baltimore, Md. : 1950). 2008;181(10):7090-7099. DOI: 10.4049/jimmunol.181.10.7090. PMID: 18981129.
[2] Hansdottir S et al. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. Journal of immunology (Baltimore, Md. : 1950). 2010;184(2):965-974. DOI: 10.4049/jimmunol.0902840. PMID: 20008294.
[3] Vargas Buonfiglio LG et al. Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial. BMJ open respiratory research. 2017;4(1):e000211. DOI: 10.1136/bmjresp-2017-000211. PMID: 28883932.
[4] Mapes B et al. Ex vivo culture of primary human colonic tissue for studying transcriptional responses to 1α,25(OH)2 and 25(OH) vitamin D. Physiological genomics. 2014;46(8):302-308. DOI: 10.1152/physiolgenomics.00194.2013. PMID: 24550213.
[5] Wu S et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut. 2015;64(7):1082-1094. DOI: 10.1136/gutjnl-2014-307436. PMID: 25080448.
[6] Chen J et al. Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to Citrobacter rodentium through modulation of innate lymphoid cells. Mucosal immunology. 2015;8(3):618-626. DOI: 10.1038/mi.2014.94. PMID: 25315967.
[7] Lin YD et al. Vitamin D Is Required for ILC3 Derived IL-22 and Protection From Citrobacter rodentium Infection. Frontiers in immunology. 2019;10:1. DOI: 10.3389/fimmu.2019.00001. PMID: 30723466.
[8] He L et al. Vitamin D/Vitamin D Receptor Signaling Is Required for Normal Development and Function of Group 3 Innate Lymphoid Cells in the Gut. iScience. 2019;17:119-131. DOI: 10.1016/j.isci.2019.06.026. PMID: 31272068.
[9] Raftery T et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. United European gastroenterology journal. 2015;3(3):294-302. DOI: 10.1177/2050640615572176. PMID: 26137304.
[10] Jolliffe DA et al. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). BMJ (Clinical research ed.). 2022;378:e071230. DOI: 10.1136/bmj-2022-071230. PMID: 36215226.
Related reading
Vitamin D Is Required for ILC3 Derived IL-22 and Protection From Citrobacter rodentium Infection
Citrobacter rodentium is a gastrointestinal infection that requires early IL-22 from group 3 innate lymphoid cells (ILC3) for resistance.
Original paper ↗Read more →Vitamin D, Mucosal Surveillance and Local Gut and Airway Defence: Full Evidence Review
Local vitamin D activation, antimicrobial responses and gut-airway differences, with animal contradictions and human respiratory-trial limitations.
Read more →Diet Is Associated with Frailty in Lung Cancer: A Possible Role of Gut Microbiota
This study investigated the associations between diet and frailty in lung cancer patients and the potential role of the gut microbiota involved.
Original paper ↗Read more →Dynamic changes in gut microbiota and metabolites in advanced lung cancer patients with immune-related adverse events
Compared to baseline, there were significant changes in gut microbiota and metabolites during the onset of irAEs, and the abundance of Veillonella increased during irAEs onset.
Original paper ↗Read more →Prenatal dietary supplements influence the infant airway microbiota in a randomized factorial clinical trial
Maternal dietary interventions during pregnancy with fish oil and high dose vitamin D have been shown to reduce the incidence of asthma and wheeze in offspring, potentially through microbial effects in pregnancy or early childhood.
Original paper ↗Read more →Vitamin D and allergic airway disease shape the murine lung microbiome in a sex-specific manner
In the current study, we examined in more depth the effects of vitamin D deficiency initiated early in life, and subsequent supplementation with dietary vitamin D on the composition of the lung microbiome and the extent of respiratory inflammation.
Original paper ↗Read more →Vitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Full Evidence Review
Gut, lung and skin studies compared: what vitamin D signalling reveals about barrier failure, and what human trials do and do not establish.
Read more →Vitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Study Summary
Compare gut, lung and skin barrier findings in plain English, including differences between experimental models and human supplement trials.
Read more →Systemic and local cytokine profile and risk factors for persistent allergic airway inflammation in patients sensitised to house dust mite allergens
To evaluate cytokine profile, vitamin D status, symptom score and quality of life in patients with persistent allergic airway diseases sensitised to house dust mites (HDM) in comparison with healthy individuals.
Original paper ↗Read more →3′‐Sialyllactose Prevents Atherosclerosis by Attenuating Chronic Inflammation via the Gut‐Immune‐Cardiovascular Axis in LDLR −/− Mice
Herein, 40 male low‐density lipoprotein receptor knockout (LDLR −/−) mice were randomized into five groups: normal diet (ND), high‐cholesterol diet (HCD), and three 3′‐SL groups (low dose SLL, medium dose SLM, high dose SLH).
Original paper ↗Read more →Associations between dietary fat-soluble vitamins and pulmonary function and airway inflammation: A cross-sectional study
Pulmonary function and airway inflammation are key indicators of respiratory health.
Original paper ↗Read more →Bile acid metabolites enhance expression of cathelicidin antimicrobial peptide in airway epithelium through activation of the TGR5-ERK1/2 pathway
Signals for the maintenance of epithelial homeostasis are provided in part by commensal bacteria metabolites, that promote tissue homeostasis in the gut and remote organs as microbiota metabolites enter the bloodstream.
Original paper ↗Read more →Changes in Gut Microbiota and Systemic Inflammation after Synbiotic Supplementation in Patients with Systemic Lupus Erythematosus: A Randomized, Double-Blind, Placebo-Controlled Trial
This study investigated whether synbiotics could improve gut microbiota and systemic inflammation in lupus patients.
Original paper ↗Read more →Inflammation: and Gut-Homing Macrophages, Engineered to De Novo Overexpress Active Vitamin D, Promoted the Regenerative Function of Intestinal Stem Cells
Available drugs aim to suppress gut inflammation.
Original paper ↗Read more →Local nebulization of 1α,25(OH)2D3 attenuates LPS-induced acute lung inflammation
In this study, we investigated if local delivery of vitamin D to the lungs improves vitamin D-mediated anti-inflammatory action in response to acute inflammation without inducing hypercalcemia.
Original paper ↗Read more →Maternal vitamin D deficiency impairs Treg and Breg responses in offspring mice and deteriorates allergic airway inflammation
This study aimed at investigating the effects of maternal VitD-deficiency during pregnancy on Treg and Breg responses in offspring mice with house dust mite (HDM)-induced allergic airway inflammation.
Original paper ↗Read more →Multi-omics analyses unveil gut microbiota and metabolites signatures in deoxycholic acid-associated intestinal inflammation
High-fat diet (HFD) is closely related to the increased incidence of inflammatory bowel disease (IBD), and excessive fecal deoxycholic acid (DCA) induced by HFD makes significant contribution to the colonic inflammation.
Original paper ↗Read more →Role of Increasing Body Mass Index in Gut Barrier Dysfunction, Systemic Inflammation, and Metabolic Dysregulation in Obesity
Results: The statistical analyses of the clinical parameters were based on the full sample set, whereas a subset composed of 37 randomized patients was inspected for the GC/MS metabolite profiling of fecal specimens.
Original paper ↗Read more →The epithelial barrier: a Janus-faced regulator in allergic airway diseases from defense to inflammation
We also evaluate contemporary diagnostic technologies for assessing the epithelial barrier and analyze current therapeutic strategies aimed at its restoration.
Original paper ↗Read more →The Role of Vitamin D in Gastrointestinal Homeostasis and Gut Inflammation
Gastrointestinal homeostasis describes a delicate state of equilibrium in which various systems cooperate to maintain digestive health, support microbial activity, and regulate immune responses.
Original paper ↗Read more →Researchers follow vitamin D and gut inflammation over 12 weeks
Medical News Today reported on changes in symptoms and immune markers among 48 adults with inflammatory bowel disease.
Read more →Original sources
Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense
Published in Journal of immunology (Baltimore, Md. : 1950) (2008).
Publication details
[1] Hansdottir S et al. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. Journal of immunology (Baltimore, Md. : 1950). 2008;181(10):7090-7099. DOI: 10.4049/jimmunol.181.10.7090. PMID: 18981129.
Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state
Published in Journal of immunology (Baltimore, Md. : 1950) (2010).
Publication details
[2] Hansdottir S et al. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. Journal of immunology (Baltimore, Md. : 1950). 2010;184(2):965-974. DOI: 10.4049/jimmunol.0902840. PMID: 20008294.
Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial
Published in BMJ open respiratory research (2017).
Publication details
[3] Vargas Buonfiglio LG et al. Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial. BMJ open respiratory research. 2017;4(1):e000211. DOI: 10.1136/bmjresp-2017-000211. PMID: 28883932.
Ex vivo culture of primary human colonic tissue for studying transcriptional responses to 1α,25(OH)2 and 25(OH) vitamin D
Published in Physiological genomics (2014).
Publication details
[4] Mapes B et al. Ex vivo culture of primary human colonic tissue for studying transcriptional responses to 1α,25(OH)2 and 25(OH) vitamin D. Physiological genomics. 2014;46(8):302-308. DOI: 10.1152/physiolgenomics.00194.2013. PMID: 24550213.
Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis
[5] Wu S et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis.
Publication details
[5] Wu S et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut. 2015;64(7):1082-1094. DOI: 10.1136/gutjnl-2014-307436. PMID: 25080448.
Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to Citrobacter rodentium through modulation of innate lymphoid cells
Published in Mucosal immunology (2015).
Publication details
[6] Chen J et al. Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to Citrobacter rodentium through modulation of innate lymphoid cells. Mucosal immunology. 2015;8(3):618-626. DOI: 10.1038/mi.2014.94. PMID: 25315967.
Vitamin D Is Required for ILC3 Derived IL-22 and Protection From Citrobacter rodentium Infection
Citrobacter rodentium is a gastrointestinal infection that requires early IL-22 from group 3 innate lymphoid cells (ILC3) for resistance.
Publication details
[7] Lin YD et al. Vitamin D Is Required for ILC3 Derived IL-22 and Protection From Citrobacter rodentium Infection. Frontiers in immunology. 2019;10:1. DOI: 10.3389/fimmu.2019.00001. PMID: 30723466.
Vitamin D/Vitamin D Receptor Signaling Is Required for Normal Development and Function of Group 3 Innate Lymphoid Cells in the Gut
Published in iScience (2019).
Publication details
[8] He L et al. Vitamin D/Vitamin D Receptor Signaling Is Required for Normal Development and Function of Group 3 Innate Lymphoid Cells in the Gut. iScience. 2019;17:119-131. DOI: 10.1016/j.isci.2019.06.026. PMID: 31272068.
Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: Results from a randomised double-blind placebo-controlled study
Published in United European gastroenterology journal (2015).
Publication details
[9] Raftery T et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. United European gastroenterology journal. 2015;3(3):294-302. DOI: 10.1177/2050640615572176. PMID: 26137304.
Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)
Published in BMJ (Clinical research ed.) (2022).
Publication details
[10] Jolliffe DA et al. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). BMJ (Clinical research ed.). 2022;378:e071230. DOI: 10.1136/bmj-2022-071230. PMID: 36215226.